Compound Evidence File
#EC-2026-0659
Superdrol Oil
Filed under Injectable Oils. The bureau holds 52 laboratory returns for this compound from 15 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
15 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 25 May 2026 | 25 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 9.0 | 8.3 | 10.0 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 3 | 8.8 | 7.0 | 10.0 | 21 May 2026 | 21 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.7 | 6.8 | 10.0 | 23 May 2026 | 23 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 8.6 | 7.9 | 9.5 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 8.3 | 7.0 | 9.3 | 23 May 2026 | 23 May 2026 |
| Top PeptideCASE #VI-2026-0721 | X | 1 | 7.5 | 7.5 | 7.5 | 24 Apr 2025 | 24 Apr 2025 |
| Nuscience PeptidesCASE #VI-2026-0554 | X | 3 | 7.2 | 5.7 | 9.5 | 20 Jun 2025 | 26 Jan 2026 |
| InjectifyCASE #VI-2026-0387 | X | 2 | 7.2 | 5.9 | 8.4 | 8 Jul 2025 | 26 Jan 2026 |
| Biolongevity LabsCASE #VI-2026-0442 | X | 1 | 6.5 | 6.5 | 6.5 | 24 Apr 2025 | 24 Apr 2025 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | E | 4 | 6.3 | 5.1 | 8.7 | 27 Feb 2025 | 19 Jan 2026 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 3 | 6.2 | 4.4 | 7.7 | 9 Jun 2025 | 19 Jan 2026 |
| Heman Peptide HMCASE #VI-2026-0089 | X | 2 | 4.3 | 3.6 | 5.1 | 13 Jun 2025 | 17 May 2026 |
| Peptide ArkCASE #VI-2026-0350 | X | 1 | 1.6 | 1.6 | 1.6 | 14 Jan 2025 | 14 Jan 2025 |
Open any subject to view the batch-level evidence for Superdrol Oil alone.